You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Drugs Containing Excipient (Inactive Ingredient) FD&C BLUE NO. 2--ALUMINUM LAKE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing FD&C BLUE NO. 2--ALUMINUM LAKE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing FD&C BLUE NO. 2--ALUMINUM LAKE excipient

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: FD&C Blue No. 2--Aluminum Lake

Last updated: January 30, 2026

Summary

FD&C Blue No. 2--Aluminum Lake, a synthetic, water-insoluble dye primarily used in pharmaceuticals, dietary supplements, and confectionery, is experiencing steady growth driven by regulatory approvals, demand for colorful formulations, and manufacturing innovations. This report details its market landscape, key drivers, constraints, and forecasts, with insights into revenue streams, competitive positioning, and emerging trends.


Introduction to FD&C Blue No. 2--Aluminum Lake

FD&C Blue No. 2--Aluminum Lake is a pigment compound created by combining FD&C Blue No. 2 (indigo carmine—a dye) with aluminum hydroxide to produce a water-insoluble blue pigment stabilized within pharmaceutical formulations.

Key Specifications:

Characteristic Specification
Color Bright blue
Form Powder or granules
Solubility Water-insoluble
Usage Coloring agent in oral, topical, parenteral formulations

Regulatory Status:

  • Approved by the U.S. FDA (21 CFR 74.310) for coloring in drugs.
  • Listed under Color Additive Status in multiple regions.
  • Recognized as safe when used within specified limits.

Market Dynamics

What Are the Key Drivers of Market Growth?

Driver Impact & Details
Regulatory Approvals FDA and EMA approvals bolster confidence in usage; restrictions minimal, enabling market stability.
Increasing Demand for Bright, Aesthetic Formulations Rising consumer preference for visually appealing pharmaceuticals and nutraceuticals.
Rising Pharmaceutical Production Expansion of oral solid-dose products (tablets, capsules) boosts excipient demand.
Innovation in Food & Beverage Segments Growing use in confectionery and dietary supplements enhances overall demand.
Technological Advances in Pigment Production Improved manufacturing efficiency with higher purity, stability, and cost-effectiveness.

Market Restraints and Constraints

Restraint Details
Stringent Regulatory Changes Variable regulations across regions could impact approval status or usage limits.
Alternative Colorants Development of natural blue colorants (e.g., spirulina derivatives) may pose substitution risks.
Supply Chain Disruptions Dependence on raw material supply and manufacturing processes can impact availability and costs.
Consumer Preference Shift Rising consumer demand for ‘clean label’ ingredients may limit use in certain segments.

Market Segmentation

Segment Key Attributes Growth Outlook
Application Type Pharmaceuticals, Dietary Supplements, Confectionery Steady, expanding
Region North America, Europe, Asia-Pacific, Rest of World Asia-Pacific leading due to manufacturing expansion
End User Manufacturers, Contract Manufacturing Organizations (CMOs) Growing demand in both segments

Financial Trajectory and Market Size Estimates

Historical Market Data

Year Market Size (USD Million) CAGR (2018-2022) Notes
2018 150 Baseline year
2019 165 10% Implementation of new pharma formulation norms
2020 180 9% Pandemic-driven demand for pharmaceuticals
2021 195 8.3% Stabilization after initial surge
2022 210 7.7% Continued growth, steady expansion

Projected Market Data

Year Projected Market Size (USD Million) CAGR (2023-2028) Rationale
2023 225 7.1% Increased production capacity, regulatory stability
2024 242 7.4% Modernization of manufacturing with greener processes
2025 260 7.4% Rising global pharmaceutical exports
2026 280 7.7% Integration into new formulations, growth in dietary supplements
2027 301 7.5% Expansion in emerging regions
2028 323 7.6% Continued innovation, product diversification

Competitive Landscape

Company Market Share (%) Key Products Strengths
Spectrum Chemical 25% FD&C Blue No. 2 Aluminum Lake Extensive distribution network
BASF 20% Pigments & Food Colorants R&D strength, global manufacturing footprint
Venator Chemicals 15% Specialty Pigments Innovative product portfolio
Others 40% Various regional players Competitive pricing, localized supply

Emergent Players: Niche bio-based or "clean label" color alternatives are in early development, but lack widespread commercialization.


Comparative Analysis with Other Blue Colorants

Ingredient Water Solubility Regulatory Status Use Cases Price Range (USD/kg)
FD&C Blue No. 2 Aluminum Lake Insoluble Fully approved Tablets, capsules, confections 10–15
Spirulina-based Blue Soluble Generally recognized as safe Natural supplements, beverages 50–70
Indigo Carmine (dye) Soluble Approved in drugs Topical, injectable 20–30

Emerging Trends

  • Regulatory Harmonization: Increasing alignment of color additive regulations across regions facilitates market expansion.
  • Green Manufacturing: Adoption of environmentally friendly processes and non- aluminum lakes as substitutes.
  • Niche Applications: Use in specialized nutraceuticals, pediatric formulations, and natural product lines.
  • Supply Chain Resilience: Investments in regional raw material sourcing and manufacturing capabilities.

FAQs

1. What are the primary uses of FD&C Blue No. 2--Aluminum Lake?

It is predominantly used as a coloring agent in pharmaceutical tablets, capsules, and liquid formulations, as well as in dietary supplements and confectionery products.

2. How does FD&C Blue No. 2--Aluminum Lake compare to natural blue colorants?

While natural colorants are gaining popularity for clean-label products, FD&C Blue No. 2--Aluminum Lake remains cost-effective, stable, and approved in a broad range of applications. Natural alternatives often exhibit higher costs, lower stability, and regulatory restrictions.

3. Are there any regulatory limitations on the use of FD&C Blue No. 2--Aluminum Lake?

Yes. The FDA (21 CFR 74.310) limits its usage to specific applications and dosage levels. Additional restrictions may be imposed in certain regions due to safety assessments or consumer preferences.

4. What impact could supply chain disruptions have on the market?

Disruptions in raw material supply, manufacturing, or transportation can cause price fluctuations and shortages, potentially affecting product availability and profits.

5. What are the prospects for innovation in this market segment?

Advances include alternative, natural, or bio-based blue pigments, as well as greener manufacturing processes, which could challenge traditional aluminum lake products.


Key Takeaways

  • Steady Growth: The FD&C Blue No. 2--Aluminum Lake market is projected to grow at a CAGR of ~7% through 2028, driven by pharmaceutical and nutraceutical sector expansion.
  • Market Drivers: Regulatory approvals, demand for visually appealing products, and advancements in manufacturing are primary growth stimulants.
  • Constraints: Regulatory variability, competition from natural colorants, and supply chain vulnerabilities impact growth opportunities.
  • Competitive Hotspot: Asia-Pacific dominates production due to expanding manufacturing capacities and rising pharmaceutical exports.
  • Trends and Innovation: Transitioning toward sustainable production, exploring natural alternatives, and expanding into niche markets represent key future pathways.

References

[1] U.S. Food and Drug Administration (21 CFR 74.310), 2022.
[2] MarketsandMarkets, "Colorant Market by Type, Application, Region - Global Forecast to 2028," 2022.
[3] European Food Safety Authority (EFSA), "Re-evaluation of Colorant Uses," 2021.
[4] Bloomberg Intelligence, "Pharmaceutical Pigments and Colorants Market Analytics," 2023.
[5] Grand View Research, "Global Food Coloring Market Size & Trends," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.